-
The Cost Burden
Serious illness is a leading factor in personal-bankruptcy cases in the United States. There’s a complex web around who is paying for care: Hospitals? Insurance companies? Patients themselves? -
Rep. Greg Walden Discuss Bipartisanship Solutions to Lower Drug Prices
What’s to be done about high drug prices, and can we find a bipartisan solution?Comments
No comments yet. Create an account and log in to post a comment.
-
Discussing Drug Pricing
Scott Gottlieb, Commissioner of the US Food and Drug Administration discusses drug pricing.Comments
No comments yet. Create an account and log in to post a comment.
-
How can Innovations in Biopharma Deliver Value?
What are the novel models delivering breakthroughs? How can precision and partnership drive value? -
Demystifying Drug Pricing
The future of prescription drugs.Comments
No comments yet. Create an account and log in to post a comment.
Comments